We are pleased to announce SCAF’s special partnership withAruvant Sciences, a biopharmaceutical company whose mission is to bring hope to Sickle Cell Disease patients by developing life-changing and potentially curative therapies.As part of our partnership, Aruvant has agreed to be SCAF’s title sponsor this year for several key events and programs.
For more info please visit www.momentumtrials.com to learn about Aruvant’s SCD trial that is currently enrolling.
Lisa Meathchem and daughter, Samone Meatchem chat with Liz Bonis, Health Reporter and Dr. Charles Quinn of Cincinnati Childrens about the impact that the opioid crisis is having on the treatment sickle cell patients receive during a pain crisis.
Taryn Walker, 15 and King Walker, 13, got to meet donors who are helping to save the siblings lives. Both Taryn and King have Sickle Cell disease and rely upon blood transfusions to keep them alive. The pair had the honor of meeting local donors at a reception hosted by Hoxworth Blood Center on July 31, 2019. Source: WLWT
Researchers at local hospital work to find the perfect dosing of Hydroxyurea for youngsters with sickle cell. Patrick McGann and Anu Marahatta use pharmacology software and several drops of patients' blood to personalize the dosage of a sickle cell drug. Source: WVXU